| |
|
Form Serial Number: |
CS20260911E00562 |
| 1.
Date of relevant event: |
08/09/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02453 |
| 4.
Name of listed corporation: |
Concord Healthcare Group Co., Ltd. |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
313,874,624 |
| 7.
Name of substantial shareholder: |
Ascendium Group Limited |
| 8.
Registered office: |
P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
Concord Medical Services Holdings Limited; New York Stock Exchange |
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1305 | There has been a change in nature of your interest in the shares because:
you have provided an interest in the shares as security to a person other than a qualified lender |
|
| 2201 | Interest of corporation controlled by you |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
35,602,300 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 63,859,100 | 20.35 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 63,859,100 | 20.35 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | N | |
| Tianjin Concord Medical Technology Co., Ltd. | K52. 11/F, Door 2, Block D, No. 1 Gonghua Road, Huayuan Industrial Zone, Binhai High Tech Zone, Tianjin, PRC; People's Republic of China | Medstar (Shanghai) Enterprise Management Co., LTD | 100.00 | Y | |
| Concord Hospital Management Group Limited | Room 1701, 9 Chong Yip Street, Kwun Tong, Kowloon, Hong Kong; Hong Kong | Ascendium Group Limited | 100.00 | N | |
| Beijing Concord Medical Technology Co., Ltd. | Room 2702, Block A, No. 36, North Third Ring East Road, Dongcheng District, Beijing, PRC; People's Republic of China | Concord Hospital Management Group Limited | 100.00 | Y | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
On September 8, 2026, Beijing Concord Medical Technology Co., Ltd. has fully released the pledge of the 35,602,300 H shares in favor of China Credit as a security for the loan facility. On the same date, Beijing Concord Medical Technology Co., Ltd. has pledged 35,602,300 H shares in favor of China Credit Trust Co., Ltd. as security for a loan facility. Please refer to the announcements of the Company dated September 8, 2026.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
11/09/2026
(dd/mm/yyyy)
|
|
|
|
|